臨牀消化器内科 Vol.26 No.10(2-3)


特集名 食道癌の治療戦略
題名 表在食道癌の治療戦略 (3) 表在食道癌内視鏡的相対適応病変に対するESDの有用性と問題点
発刊年月 2011年 09月
著者 竹内 学 新潟大学医歯学総合研究科消化器内科学分野
著者 橋本 哲 新潟大学医歯学総合研究科消化器内科学分野
著者 小林 正明 新潟大学医歯学総合病院光学医療診療部
著者 佐藤 祐一 新潟大学医歯学総合研究科消化器内科学分野
著者 成澤 林太郎 新潟大学医歯学総合病院光学医療診療部
著者 青柳 豊 新潟大学医歯学総合研究科消化器内科学分野
【 要旨 】 食道癌の内視鏡的相対適応病変は,壁深達度T1a-EP/LPMかつ周在性2/3以上あるいは臨床的に転移がない壁深達度T1a-MM,SM1の病変とされている.技術的には両病変とも内視鏡的粘膜下層剝離術(ESD)にて安全な一括完全切除が可能であるが,前者では術後狭窄,後者ではリンパ節転移を10〜15%に認めることが問題である.術後狭窄に対しては,ステロイド局注療法の導入により亜全周切除例の約70%で内視鏡的バルーン拡張術(EBD)が不要であり,全周切除例ではEBD施行回数をEBD単独群に比べ減らすことが可能であった.また,ESD切除標本の詳細な病理組織学的検討を行い,リンパ節転移危険因子(脈管侵襲陽性,低分化型癌,INFb,c)の有無により追加治療の要否を判定することで,T1a-MM,SM1に対する内視鏡治療の成績は良好であった.以上より,現段階では相対適応病変に対するESDは妥当であると思われる.
Theme Current Status of Uprising Strategy for Esophageal Cancer Treatment
Title Efficacy of and Problems with Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Treatment
Author Manabu Takeuchi Department of Gastroenterology, Niigata University Graduate School of Medical and Dental Sciences
Author Satoru Hashimoto Department of Gastroenterology, Niigata University Graduate School of Medical and Dental Sciences
Author Masaaki Kobayashi Department of Endoscopy, Niigata University Medical and Dental Hospital
Author Yuichi Sato Department of Gastroenterology, Niigata University Graduate School of Medical and Dental Sciences
Author Rintaro Narisawa Department of Endoscopy, Niigata University Medical and Dental Hospital
Author Yutaka Aoyagi Department of Gastroenterology, Niigata University Graduate School of Medical and Dental Sciences
[ Summary ] Esophageal squamous cell carcinoma (SCC) involving the epithelium (EP) or the lamina propria mucosa (LPM) and spreading more than two-thirds of the circumference of the esophagus is considered to be a relative indication for endoscopic resection (ER). This is because of the likelyhood of post-operative strictures. Moreover, ER may indicate MM (muscularis mucosa) or SM1 (< 200 micrometers below the MM) without metastasis being observed through clinical examinations because lymphnode metastasis rates are reported to be approximately 10-15 % for MM or SM1 SCC. However, endoscopic submucosal dissection (ESD) enables us to resect both types of lesions in an en-bloc fashion with no complications.To prevent post operative strictures, we began injecting steroids into artificial ulcer bases after ESD.Additional endoscopic balloon dilation (EBD) was unnecessary in approximately 70 % of semi circumferential ESD cases.Less post EBD treatment was required when employing circumferential ESD than when employing EBD alone.Prognoses for MM or SM1 SCC are considered to be good with additional therapies, such as esophagectomy or chemoradiotherapy, which are based on histopathological examination of ESD resected specimens. At the present time, ESD treatment for lesions with relative indications for ER is considered to be appropriate.
戻る